Racial disparities still seen in use of breast cancer treatments

December 5, 2012
Racial disparities still seen in use of breast cancer treatments
Black women less likely than whites to undergo less invasive procedures for staging the disease, study finds.

(HealthDay)—Black women with breast cancer are less likely than their white peers to benefit from improved surgical techniques used to treat their disease, according to a new study.

After examining five years of data, researchers in Houston found black women were 12 percent less likely than white women to undergo less invasive procedures for staging , such as sentinel lymph node biopsy. They advised that these improved techniques should be more widely used.

In a sentinel lymph node biopsy, the first lymph node (gland) to which cancer cells are most likely to spread is identified, surgically removed and checked to see if cancer cells are present.

The study findings were scheduled for presentation Wednesday at the San Antonio Breast Cancer Symposium.

"These findings are an example of the need for continued improvements in disseminating national practice guidelines for breast cancer to surgeons and other breast cancer providers in all of our communities," Dr. Dalliah Mashon Black, an assistant professor of surgery in the department of surgical oncology at the University of Texas M.D. Anderson Cancer Center in Houston, said in a news release from the American Association for Cancer Research.

"When we think of disparities, it doesn't only mean that patients might be undertreated, but they could be overtreated with unnecessary and more radical procedures," Black added.

In conducting the study, the researchers examined Medicare data from 2002 to 2007 on more than 31,000 women aged 66 or older. Of these women, nearly 1,800 were black, just under 28,000 were white and about 1,650 were of another or unknown race.

The investigators found that 62 percent of black women underwent sentinel lymph node biopsy. Meanwhile, 74 percent of white women had this less invasive procedure. Although the use of this type of biopsy increased every year for all of the women, disparities continued to exist in 2007.

"From 2002, when surgeons were still incorporating [sentinel lymph node] biopsy into practice, until 2007, black women were less likely to have undergone [sentinel lymph node] biopsy than were ," Black noted. "The fact that this disparity continued over time shows that new and improved surgical therapies may not be effectively implemented in some patient populations."

Black women were much less likely to receive sentinel lymph node biopsy despite the size of their tumor, their sociodemographics and the type of surgery they had, the results showed.

The study authors pointed out that the more invasive biopsy, known as an axillary lymph node dissection, is effective but associated with more short-term and long-term complications. And who underwent this more invasive procedure had twice the risk for lymphedema—a painful, arm-swelling condition—than other women treated with sentinel lymph , they noted.

The researchers said they plan to update their findings with information from the 2010 Surveillance, Epidemiology and End Results-Medicare database to determine if improvements have been made since 2007.

The data and conclusions of research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

Explore further: Breast cancer patients with positive ultrasound guided axillary node biopsy need dissection

More information: The U.S. National Library of Medicine has more about health disparities.

Related Stories

Breast cancer patients with positive ultrasound guided axillary node biopsy need dissection

May 3, 2012
Contrary to a trend in treatment, breast cancer patients with suspicious lymph nodes should have an ultrasound-guided axillary node biopsy, and if that biopsy is positive these patients should undergo an axillary dissection, ...

Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy

December 5, 2012
Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to see if any cancer remains. A study conducted through the American College of ...

African American women with breast cancer less likely to have newer, recommended surgical procedure

December 5, 2012
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, ...

New guidelines issued for biopsy use in melanoma patients

July 9, 2012
(HealthDay) -- Sentinel lymph node biopsy -- a minimally invasive surgical technique that lets doctors see whether cancer has spread -- should be performed on patients with melanoma tumors of intermediate thickness and may ...

Sentinel node biopsy safe, effective in head and neck melanomas

August 5, 2011
A common technique for determining whether melanoma has spread can be used safely and effectively even in tumors from the head and neck area, according to a new study from the University of Michigan Comprehensive Cancer Center.

'Hidden' cancer cells not a factor in early-stage breast cancer survival rates

July 26, 2011
A new study shows that removing lymph nodes due to the presence of occult, or microscopic, cancer cells found in the sentinel lymph node – the one closest to the tumor -- has no impact on survival outcomes of women with ...

Recommended for you

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.